

Dergi
Balkan Medical Journal
Cilt
43
ISSN
21463123
Yayın Tarihi
1 Ocak 2026
Background: Accurate identification of medulloblastoma molecular 4 (G3/4). nLEF1 demonstrated higher specificity and sensitivity for WNT-subgroups is essential, particularly in settings lacking advanced genomic AG than β-catenin, identifying it as a more reliable diagnostic marker. tools. Conventional markers, such as β-catenin, present significant High pLEF1 expression was strongly associated with SHH-AG. Cyclin D1 challenges in reliably detecting the WNT-activated subgroup (WNT-AG). positivity was predominantly observed in WNT-AG. While ROR2 did not Aims: To evaluate the utility of lymphoid enhancer-binding factor 1 identify WNT-AG effectively, its absence in Group 3 cases was notable. (LEF1), Cyclin D1, and receptor tyrosine kinase-like orphan receptor 2 Prognostic analysis revealed that LEF1 expression patterns correlated (ROR2) as immunohistochemical (IHC) markers for molecular subgroup with favorable survival outcomes: total LEF1 (tLEF1) and nLEF1 were classification and to assess their prognostic significance. associated with improved overall survival, whereas pLEF1 and tLEF1 were Study Design: Retrospective cohort study. linked to better progression-free survival. Methods: IHC analysis was performed using LEF1, Cyclin D1, and ROR2. Conclusion: Nuclear LEF1 (nLEF1) is at least as effective as β-catenin in Two distinct LEF1 staining patterns were identified: nuclear (nLEF1) and identifying WNT-AG and may serve as a superior diagnostic marker. Cyclin punctate (pLEF1). A subset of 29 cases, selected based on predefined D1 can be used as a complementary marker in WNT-AG detection. ROR2 criteria, underwent EPIC array Methylation analysis. Findings were negativity may indicate G3 tumors, though further studies are warranted correlated with recurrence and survival outcomes. to confirm its prognostic value. Results: Among the 94 cases, 12.8% were WNT-AG, 54.3% were sonic hedgehog-activated subgroup (SHH-AG), and 33.0% were Groups 3 and